Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Brandner

Showing results (281-290 of 369) with videos related to

Pageof 37
Sort By:
Neuro-Oncology Advances|December 18, 2023
Direct image to subtype prediction for brain tumors using deep learningKatherine J Hewitt, Chiara M L Löffler, Hannah Sophie Muti, et al.
Acta Neuropathologica|April 28, 2023
Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genesLucas Hoffmann, Roland Coras, Katja Kobow, et al.
Neuroimage. Clinical|August 25, 2022
Resection of dominant fusiform gyrus is associated with decline of naming function when temporal lobe epilepsy manifests after the age of five: A voxel-based lesion-symptom mapping studyCaroline Reindl, Anna-Lena Allgäuer, Benedict A Kleiser, et al.
Clinical and Translational Medicine|August 7, 2025
Role of somatostatin receptor 2 (SSTR2) in pituitary adenomasYvonne Power, Jacklyn Liu, Umar Rehman, et al.
JAMA Neurology|February 24, 2016
Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob DiseaseSimon Mead, Matthew Burnell, Jessica Lowe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2017
Genetic and clinical characteristics of <i>NEFL</i>-related Charcot-Marie-Tooth diseaseAlejandro Horga, Matilde Laurà, Zane Jaunmuktane, et al.
Acta Neuropathologica|March 27, 2023
Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genesLucas Hoffmann, Roland Coras, Katja Kobow, et al.
Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.
Cell Reports|July 13, 2017
A PML/Slit Axis Controls Physiological Cell Migration and Cancer Invasion in the CNSValeria Amodeo, Deli A, Joanne Betts, et al.
Neurology. Genetics|May 24, 2019
Autosomal dominant optic atrophy and cataract "plus" phenotype including axonal neuropathyAlejandro Horga, Enrico Bugiardini, Andreea Manole, et al.
Pageof 37

Showing results (281-290 of 369) with videos related to

Sort By:
Pageof 37
Neuro-Oncology Advances|December 18, 2023
Direct image to subtype prediction for brain tumors using deep learningKatherine J Hewitt, Chiara M L Löffler, Hannah Sophie Muti, et al.
Acta Neuropathologica|April 28, 2023
Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genesLucas Hoffmann, Roland Coras, Katja Kobow, et al.
Neuroimage. Clinical|August 25, 2022
Resection of dominant fusiform gyrus is associated with decline of naming function when temporal lobe epilepsy manifests after the age of five: A voxel-based lesion-symptom mapping studyCaroline Reindl, Anna-Lena Allgäuer, Benedict A Kleiser, et al.
Clinical and Translational Medicine|August 7, 2025
Role of somatostatin receptor 2 (SSTR2) in pituitary adenomasYvonne Power, Jacklyn Liu, Umar Rehman, et al.
JAMA Neurology|February 24, 2016
Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob DiseaseSimon Mead, Matthew Burnell, Jessica Lowe, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 15, 2017
Genetic and clinical characteristics of <i>NEFL</i>-related Charcot-Marie-Tooth diseaseAlejandro Horga, Matilde Laurà, Zane Jaunmuktane, et al.
Acta Neuropathologica|March 27, 2023
Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genesLucas Hoffmann, Roland Coras, Katja Kobow, et al.
Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.
Cell Reports|July 13, 2017
A PML/Slit Axis Controls Physiological Cell Migration and Cancer Invasion in the CNSValeria Amodeo, Deli A, Joanne Betts, et al.
Neurology. Genetics|May 24, 2019
Autosomal dominant optic atrophy and cataract "plus" phenotype including axonal neuropathyAlejandro Horga, Enrico Bugiardini, Andreea Manole, et al.
Pageof 37